Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Matawan, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Apimeds Pharmaceuticals US, Inc. has filed 118 SEC EDGAR filings since 29 Jan 2024

SEC filing history

Showing 76-100 of 118 matching filings.

Per page
25
Current page
4
3

PRIMARY DOCUMENT

Filing date
08 May 2025
Reporting date
04 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-282324

EFFECT filing

Filing date
05 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 001-42545

UPLOAD filing

Filing date
05 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-282324

POST-EFFECTIVE AMENDMENT

Filing date
02 May 2025
Reporting date
Not listed
Next action
Verify source filing
10-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 10-K

Filing date
02 May 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-282324

POST-EFFECTIVE AMENDMENT

Filing date
01 May 2025
Reporting date
Not listed
Next action
Verify source filing
UPLOAD File 001-42545

UPLOAD filing

Filing date
01 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-282324

UPLOAD filing

Filing date
30 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-282324

POST-EFFECTIVE AMENDMENT

Filing date
17 Apr 2025
Reporting date
Not listed
Next action
Verify source filing
10-K File 001-42545

ANNUAL REPORT

Filing date
15 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
15 Apr 2025
Reporting date
11 Apr 2025
Next action
Verify source filing
NT 10-K File 001-42545

NOTIFICATION OF LATE FILING

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-42545

NYSE AMERICAN CERTIFICATION

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-42545

FOR REGISTRATION OF CERTAIN CLASSES

Filing date
03 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-282324

EFFECT filing

Filing date
11 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-282324

FREE WRITING PROSPECTUS

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 377-07074

UPLOAD filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .